Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

GlaxoSmithKline Pharmaceuticals delivers strong H1 performance

Posted On: 2018-10-23 07:33:20

GlaxoSmithKline Pharmaceuticals Limited today declared its financial results for the quarter ended 30th September 2018. Revenue for the quarter ended 30th September 2018 came in at Rs. 816 crores, recording a decline of 2% as compared to the same prior year period. Profit Before Tax (PBT) was at Rs. 156 crores and Profit After Tax (PAT) at Rs. 101 crores.

The growth of the standalone quarter is not directly comparable to the prior year quarter due to the base effect of GST. Due to GST, pharmaceutical trade channels de-stocked in Q1 of last year, impacting the overall performance of the industry and re-stocked again in Q2.

Revenue for the half year ended 30th September 2018, came in at Rs. 1,552 crores, growing 8% as compared to the same prior year period. Profit Before Tax (PBT) at Rs. 295 crores and Profit After Tax (PAT) at Rs. 189 crores are higher by 24% and 21 % respectively, against the same prior year period.

Commenting on the results, A. Vaidheesh, Managing Director, GlaxoSmithKline Pharmaceuticals Limited said, "Our financial performance highlights an underlying double digit quaiterly Sales growth, underpinned by a strong volume delivery. Our new commercial operating model to invest resources in key products and patients/consumers, is in full momentum. I believe that our new structure will help us successfully fulfill our ambition of accelerated, sustainable profitable growth over the longer term.

While we will continue to manufacture and sell over 70 brands, we are now focusing our efforts on 20 key brands to drive growth in identified therapy areas where there is significant unmet patient need. We remain committed to Indian patient needs and are increasing our field force by a third, in our targeted segments. Continued optimisation of costs contributed to an improved EBITDA margin of20.5% in the quarter. Bottomline growth remains strong for the quarter and half year.

Exceptional items for the current quarter includes a charge in establishment costs because of restructuring both in commercial and at our Nashik manufacturing site, to align with our new operating model and focused therapy investment."

The Board of Directors of GSK Pharma had announced a bonus issue of shares in the ratio of one share for every one share held (1:1) on 24 July this year. The entire process of issue of bonus shares, including shareholders' approval was completed, and the bonus shares have been traded on stock exchanges since 21 September 2018.

We are glad to inform you we are on project timeline with our manufacturing facility in Vemgal, Karnataka. The site has recently passed an inspection and received its test license. We have started manufacturing validation batches, taking us a step closer to commercial production."

Shares of GLAXOSMITHKLINE PHARMACEUTICALS LTD. was last trading in BSE at Rs.1370.35 as compared to the previous close of Rs. 1423.6. The total number of shares traded during the day was 2958 in over 559 trades.

The stock hit an intraday high of Rs. 1434.9 and intraday low of 1356.35. The net turnover during the day was Rs. 4103860.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Sicagen India Ltd board to consider Q3 results on Feb 13, 2019

Delhi Airport Metro Express updates on arbitration award

SPML Infra Limited board to announce third quarter results on Feb 8, 2019

ITI Limited signs contract with Gujarat Fibre Grid Network Ltd

Swaraj Automotives Ltd board to announce third quarter results on Feb 1, 2019

HDFC Bank announces Q3 FY19 results

JK Agri Genetics Ltd board to announce Q3 results on Jan 30, 2019

K P R Mill Ltd board to consider Q3FY19 results on Jan 28, 2019

Paramount Communications Ltd board to approve 3rd quarter results on Feb 1, 2019

Sutlej Textiles and Industries Ltd board to announce third quarter results on Feb 5, 2019

PSP Projects Ltd receives new work orders worth Rs. 572.17 crores

Sarla Performance Fibers Ltd calls for board meeting on Feb 1, 2019

Bliss GVS Pharma Ltd board to consider Q3FY19 results on Jan 29, 2019

HDFC Bank appoints Mr. Sandeep Parekh as additional independent director

Governance Award for BEML

Munjal Showa Ltd board to approve quarterly results on Feb 4, 2019

IP Rings Ltd board to announce 3rd quarter results on Feb 1, 2019

Dwarikesh Sugar Industries Ltd board to announce Q3 results on Feb 2, 2019

SEBI asks Larsen & Toubro Ltd not to proceed with buyback

HDFC Bank Ltd Q3 net profit rises to Rs. 5585.85 crores

ARO Granite Industries Ltd Q3 PAT soars to Rs. 4.16 crore

Hindustan Oil Exploration Company Ltd posts jump in Q3 PAT to Rs. 34.81 crores

South Indian Bank Ltd Q3 net profit drops to Rs. 83.85 crores

Nava Bharat Ventures Ltd board to announce Q3 results on Feb 7, 2019

Freshtrop Fruits Ltd board to approve 3rd quarter results on Jan 29, 2019

Gujarat Intrux Ltd board to approve quarterly results on Jan 29, 2019

Maithan Alloys Ltd board to announce Q3 results on Jan 28, 2019

Sri Ramakrishna Mills Coimbatore Ltd calls for board meeting on Feb 13, 2019

PVR Cinemas and BookMyShow celebrate the second successful year of VKAAO

SPML Infra Ltd's Chairman received Economic Times Most Promising Business Leaders of Asia 2018 Award

DCM Shriram Industries Ltd board to approve third quarter results on Feb 2, 2019

Machino Plastics Ltd calls for board meeting on Jan 30, 2019

Honda SIEL Power Products Ltd board to announce 3rd quarter results on Feb 6, 2019

Precision Camshafts Ltd board to consider Q3 results on Feb 7, 2019

Vascon Engineers Ltd to raise Rs. 110 crores through NCD issue

Healthcare Global Enterprises Limited calls for board meeting on Feb 7, 2019

Welspun Enterprises Ltd board to consider third quarter result son Jan 29, 2019

RBI approves appointment of V Vaidyanathan as MD & CEO of IDFC First Bank Ltd

International Combustion India Ltd calls for board meeting on Feb 8, 2019

Gujarat Hotels Ltd board to approve third quarter results on Jan 30, 2019

Thangamayil Jewellery Ltd board to announce Q3FY19 results on Feb 8, 2019

Vesuvius India Ltd board to consider Q4, CY18 results on Feb 28, 2019

Rossell India Ltd board to announce 3rd quarter results on Feb 5, 2019

Entertainment Network India Ltd board to approve third quarter results on Feb 6, 2019

CEAT Ltd board to consider Q3 results on Jan 28, 2019

Minda Industries Ltd issues CP of Rs. 30 crore

Zee Learn Limited continues strong growth momentum in Q3 FY19

ICICI Lombard General Insurance Company Ltd announces Q3 results for FY2018-19

SBI Life Insurance Company Ltd announces Q3FY19 results

Omax Autos Ltd reports Q3 PAT of Rs. 1.57 crore







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019